Our Expertise

Our 50 genomic experts are based in France and the US and are dedicated to R&D, BioT, Production, and Supporting departments for cutting edge research.

| HOW WE DO IT

GMP

in France as per 2021

2

Sites: based in Paris (France) and Wayne, PA (USA)

50

employes

50% of Ph.D

BioIT

Optimized proprietary database

| OUR CONTRIBUTION

”

Ten years ago, when I founded PathoQuest, I predicted that NGS would be incorporated into the ICH guidelines and that a paradigm shift would occur in the testing of biologics. In the coming years, I am confident that the NGS will replace the entire panel of standard tests and be vastly adopted as an all-in-one test to guarantee the viral safety of biologics and innovative therapies.

Prof. Marc Eloit

Founder and scientific adviser PathoQuest & Institut Pasteur Paris

PathoQuest participates in various groups, associations, and consortia for the innovation anchoring of Next-Generation Sequencing (NGS) as a cornerstone technology to improve the biosafety of biologics.